NON SMALL CELL LUNG CANCER NSCLC
Clinical trials for NON SMALL CELL LUNG CANCER NSCLC explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER NSCLC trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo targets lung cancer brain metastases in 60-patient trial
Disease control Not yet recruitingThis study tests whether a higher dose of furmonertinib alone works better than a standard dose combined with chemotherapy for people with a specific type of lung cancer (EGFR-mutated) that has spread to the brain. About 60 adults who have not had treatment before will take part.…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 03:16 UTC
-
New hope for Hard-to-Treat cancers: drug targets RAS mutations
Disease control Not yet recruitingThis study tests an experimental drug called BPI-572270 in 120 adults with advanced solid tumors (lung, colorectal, or pancreatic cancer) that have specific RAS gene mutations. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. Participan…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE1, PHASE2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New combo therapy aims to control early lung cancer without surgery
Disease control Not yet recruitingThis study tests whether adding Huaier granules to microwave ablation (a heat-based tumor treatment) helps control stage IA non-small cell lung cancer better than ablation alone. About 180 people with inoperable early-stage lung cancer will take part. The main goal is to see if t…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE3 • Sponsor: Xin Ye • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
New drug combo aims to shrink advanced tumors
Disease control Not yet recruitingThis study tests a new drug called QLS5132 given with other cancer treatments for people with advanced solid tumors, including stomach, lung, endometrial, and ovarian cancers. The goal is to find safe doses and see if the combination can shrink tumors. About 626 participants will…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New combo targets tricky lung cancer transformation after standard therapy fails
Disease control Not yet recruitingThis study tests a combination of the targeted drug limertinib plus chemotherapy (carboplatin and etoposide) in people with a specific type of lung cancer (EGFR-mutant NSCLC) that has transformed into small cell lung cancer after initial targeted therapy stopped working. About 30…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE2 • Sponsor: Hunan Province Tumor Hospital • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New hope for advanced lung cancer: experimental drug JSKN033 enters phase II trial
Disease control Not yet recruitingThis study tests a new drug called JSKN033 in 160 people with advanced non-small cell lung cancer that cannot be cured. The goal is to see if the drug is safe and shrinks tumors. The trial has two parts: first finding the best dose, then testing it in more patients.
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE2 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
Lung cancer patients to test athletic recovery program
Symptom relief Not yet recruitingThis pilot study will enroll 10 people who had surgery for early-stage non-small cell lung cancer. Participants will follow a 6-month athletic program supervised by a sports scientist. The goal is to see if exercise can improve lung function, fitness, and quality of life after su…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: NA • Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Smart wearables could boost lung cancer surgery recovery
Knowledge-focused Not yet recruitingThis study tests a new system using wearable devices and a smartphone app to help people with non-small cell lung cancer recover after chest surgery. About 126 participants will either use the wearable system or get standard care. The goal is to see if the wearable approach impro…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: NA • Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:17 UTC
-
Can ancient chinese medicine predict lung cancer drug success?
Knowledge-focused Not yet recruitingThis study looks at how Traditional Chinese Medicine (TCM) body patterns, like tongue and pulse readings, relate to how well EGFR-TKI drugs work in people with a certain type of lung cancer. About 3000 patients will be followed for up to 5 years during their regular care. Researc…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 03:12 UTC
-
Simple blood test could predict immunotherapy success in multiple cancers
Knowledge-focused Not yet recruitingThis study aims to develop a blood test that can predict whether a patient with certain cancers (like lung, skin, or breast cancer) will benefit from immunotherapy. Researchers will analyze a specific type of white blood cell (neutrophils) from blood samples taken before treatmen…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Sponsor: OncoHost Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC